BioMarin Pharmaceutical, Inc. (BMRN) — Hedge Fund Ownership Q4 2025
BMRN
- BioMarin Pharmaceutical, Inc. (BMRN) is held by 2 of 81 tracked hedge funds, with Viking Global Investors (1%) and Dodge & Cox (0.5%) holding the largest stakes, indicating limited hedge fund interest relative to peers.
- The biggest decreases in BMRN holdings came from Viking Global Investors (-27%) and Dodge & Cox (-1%), suggesting profit-taking or de-risking.
- Overall, hedge funds decreased exposure to BioMarin Pharmaceutical, Inc. (BMRN) by -10% vs the prior quarter and -18% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Viking Global Investors Andreas Halvorsen
|
0.95% | 6.0M | -27.46% | -42.56% | $358.8M | $59.43 | — |
| 2 |
Dodge & Cox
|
0.47% | 14.6M | -0.78% | -1.18% | $866.0M | $59.43 | — |
| 2 | Total | — | 20.6M | -10.43% | -18.40% | $1.22B | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.